4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluation
…, J Seraj, AR Fuentes-Pesquera, RH Gruninger…
Index: Hughes, Terry V.; Emanuel, Stuart L.; Beck, Amanda K.; Wetter, Steven K.; Connolly, Peter J.; Karnachi, Prabha; Reuman, Michael; Seraj, Jabed; Fuentes-Pesquera, Angel R.; Gruninger, Robert H.; Middleton, Steven A.; Lin, Ronghui; Davis, Jeremy M.; Moffat, David F.C. Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 12 p. 3266 - 3270
Full Text: HTML
Citation Number: 36
Abstract
A novel series of 4-aryl-5-cyano-2-aminopyrimidines were synthesized and found to have potent VEGF-R2 kinase inhibitory activity. Structure–activity relationships were investigated and compound 14a was shown to be efficacious in a mouse model of corneal neovascularization.
Related Articles:
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds
[Niculescu-Duvaz, Dan; Niculescu-Duvaz, Ion; Suijkerbuijk, Bart M.J.M.; Menard, Delphine; Zambon, Alfonso; Nourry, Arnaud; Davies, Lawrence; Manne, Helen A.; Friedlos, Frank; Ogilvie, Lesley; Hedley, Douglas; Takle, Andrew K.; Wilson, David M.; Pons, Jean-Francois; Coulter, Tom; Kirk, Ruth; Cantarino, Neus; Whittaker, Steven; Marais, Richard; Springer, Caroline J. Bioorganic and Medicinal Chemistry, 2010 , vol. 18, # 18 p. 6934 - 6952]